Antiverse, UK-based biotech developing AI-designed therapeutic antibodies for undruggable disease targets, closed a Series A round of $9.3 million. The round was led by Soulmates Ventures with participation from Innovation Investment Capital, DOMiNO Ventures and existing investors DBW, Kadmos Capital and i&i Biotech Fund.

Yujia Du helps climate leaders drive meaningful impact authentically through coaching.

German-based healthtech company Oska Health announced an €11 million seed funding round, led by Capricorn Partners and SwissHealth Ventures.

nyra Health, developer of an AI-powered platform for neurological therapy, has successfully closed a €20 million Series A funding round.

The Gates Foundation has awarded a $5 million grant to Axmed, a Swiss health-tech startup modernizing how essential medicines are procured across emerging markets.

Events’ organizational structure and the way their agendas incorporate ESG topics play a crucial role in their carbon footprint and in shaping the conversations they drive within the startup ecosystem. 

Lifeaz, a startup based in France that aims to make defibrillators more widely available to households and organizations, has raised €13 million.

Sable Bio, a London-based AI startup focused on drug safety, has raised $3.75 million in seed funding to scale its platform that helps pharmaceutical companies identify safety risks earlier in drug discovery.